BIO-REFERENCE LABS INC-NEW-
BRLI
BRLI was delisted on the 19th of August, 2015.
182 hedge funds and large institutions have $744M invested in BIO-REFERENCE LABS INC-NEW- in 2014 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 56 increasing their positions, 63 reducing their positions, and 11 closing their positions.
145% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 11
11% more capital invested
Capital invested by funds: $673M → $744M (+$70.9M)
8% more funds holding
Funds holding: 168 → 182 (+14)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
11% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 63
60% less call options, than puts
Call options by funds: $3.61M | Put options by funds: $8.99M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$5.76M |
| 2 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$5.35M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.35M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.76M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
-$25.8M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$15.4M |
| 3 |
CM
CS McKee
Pittsburgh,
Pennsylvania
|
-$3.76M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$2.93M |
| 5 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
-$2.44M |
BRLI Hedge Fund Activity: Q4 2014 in Review
182 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in BIO-REFERENCE LABS INC-NEW- (BRLI) for Q4 2014, worth a combined $744M — up 11% from $673M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new BRLI positions and 11 closed out — a net gain of 16 holders — while 56 added to existing stakes and 63 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $5.76M. The largest seller was Sarissa Capital Management, cutting an estimated $25.8M.
- 182 institutional investors held BIO-REFERENCE LABS INC-NEW- (BRLI) as of Q4 2014, up from 168 in Q3 2014.
- Funds reported $744M of BIO-REFERENCE LABS INC-NEW- stock for Q4 2014, up 11% quarter-over-quarter.
- 27 funds opened new BIO-REFERENCE LABS INC-NEW- positions in Q4 2014 and 11 closed out, a net change of +16 holders.
- The largest BIO-REFERENCE LABS INC-NEW- buyer in Q4 2014 was Royal Bank of Canada, an estimated $5.76M added.
- The largest BIO-REFERENCE LABS INC-NEW- seller in Q4 2014 was Sarissa Capital Management, an estimated $25.8M sold.
Based on aggregated 13F filings for Q4 2014.